Scientists at Tohoku University have discovered a novel approach that improves the efficacy of immune checkpoint blockade (ICB)—a novel form of cancer treatment utilizing immune checkpoint inhibitors (ICIs)—and minimizes ...
May 31, 2023
0
8
Ketamine taken in the form of a nasal spray may prove a safe and effective treatment for refractory chronic migraine, suggests a single center study, published in Regional Anesthesia & Pain Medicine.
May 30, 2023
0
8
Cisplatin is widely used as a chemotherapeutic agent for the treatment of various solid tumors, including bladder, ovarian, and esophageal tumors. However, on metabolism by an enzyme called "cysteine conjugate beta-lyase ...
May 23, 2023
0
3
Scientists are calling for tighter regulation of stem cell treatments, after finding hundreds of clinics worldwide offering unproven "therapies" for conditions as varied as hair loss and Parkinson's.
May 22, 2023
0
11
Depression due to psychological stress affects millions of people worldwide. However, most of the existing anti-depressant drugs are slow, prone to development of resistance, and have severe side effects, demanding the need ...
May 8, 2023
0
0
Newly developed "smart" coatings for surgical orthopedic implants can monitor strain on the devices to provide early warning of implant failures while killing infection-causing bacteria, University of Illinois Urbana-Champaign ...
May 5, 2023
0
82
Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to ...
May 4, 2023
0
6
The U.S. Food and Drug Administration on Tuesday approved a new drug for people who have a rare, inherited type of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Apr 26, 2023
0
3
You can get a better effect from your training if you believe that the training program you are following has been put together especially for you, according to Kolbjørn Andreas Lindberg, a research fellow at the University ...
Apr 25, 2023
0
282
With the FDA authorizing a second bivalent booster this week for individuals at high risk from COVID-19 and the CDC expected to sign off on it as well, a recent Houston Methodist study may offer some guidance on when certain ...
Apr 19, 2023
0
6
